Non-surgical Treatment of Primary Female Urethral Cancer
Overview
Authors
Affiliations
Primary carcinomas of the female urethra are extremely rare, with an annual incidence of less than ten in one million. Currently, there is no consensus regarding management of this malignancy. However, there have been several case reports demonstrating the efficacy of chemoradiation in the treatment of female urethral cancer. In this report we present two cases of female primary urethral adenocarcinoma that were treated by concomitant chemotherapy and external beam radiotherapy, followed by interstitial brachytherapy.
Management of Primary Female Urethral Adenocarcinoma: Two Rare Case Reports and Literature Review.
Tian J, Zhu T, Xu Z, Chen X, Wu Y, Fu G Medicina (Kaunas). 2023; 59(1).
PMID: 36676733 PMC: 9865078. DOI: 10.3390/medicina59010109.
Progress in the treatment of urethral adenocarcinoma.
Guo J, Liang X, Zheng Y, Ma J J Cancer Res Clin Oncol. 2022; 149(6):2693-2698.
PMID: 36414814 DOI: 10.1007/s00432-022-04481-5.
Incidence rates and contemporary trends in primary urethral cancer.
Wenzel M, Nocera L, Colla Ruvolo C, Wurnschimmel C, Tian Z, Shariat S Cancer Causes Control. 2021; 32(6):627-634.
PMID: 33751293 PMC: 8089076. DOI: 10.1007/s10552-021-01416-2.
Bagshaw H, Williams N, Huang Y, Tward J, Gaffney D Gynecol Oncol Rep. 2015; 13:40-3.
PMID: 26425719 PMC: 4563585. DOI: 10.1016/j.gore.2015.06.001.
Magnuson W, Bradley K, Shaves M Gynecol Oncol Case Rep. 2013; 2(1):1-3.
PMID: 24371597 PMC: 3860990. DOI: 10.1016/j.gynor.2011.10.006.